Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science

Abstract

Introduction Pharmaceutical pricing has only recently gained space in mainstream health science literature. Objectives Bibliometric and content description of health science academic literature and ad hoc analysis of grey literature on factors influencing pharmaceutical pricing on databases commonly accessed by healthcare professionals. Methods Scoping study with no time limits performed in Medline, Scopus and Scielo, and relevant sites and databases for grey literature, using search terms with database-appropriate keywords . Results Two hundred four articles were published in 103 peer-reviewed journals between 1981 and 2016 (last search year). In grey literature 78 documents were retrieved in the final selection. Five key thematic clusters for analysing pharmaceutical pricing emerged: market dynamics, segmented into (i) supply-related, (ii) consumer-related and (iii) product-related; (iv) trading strategies, either buyer’s or seller’s and (v) regulatory approach. In peer-reviewed literature there is an overall dominance of themes referring to trading strategies and regulatory approaches and a wide thematic cluster scope. Over half of this literature was produced after the year 2010. International agency technical papers make up the most significant contributions of grey literature, with a clear focus on regulatory approaches to pricing and wider consideration of emerging countries. Research lags in the literature on factors affecting pharmaceutical pricing include impacts of financing schemes, market liberalization, internet trading and biosimilars on prices, with insufficient discussion identified for the effects of discounts/rebates, profits and price transparency. Conclusions Interest in pharmaceutical pricing literature is increasing. Robust evidence-producing study designs for pricing interventions will be a welcome development. Electronic supplementary material The online version of this article (10.1186/s40545-019-0183-0) contains supplementary material, which is available to authorized users.

Variabilidade de preços de aquisição de medicamentos do grupo 1B do Componente Especializado da Assistência Farmacêutica

“…Isso é comum em outros países com políticas de negociação de preços centralizada 23,42 . Revisão de estudos sobre fatores que influenciam o preço de medicamentos revelou importante aumento da produção de pesquisas na área, com destaque tanto para estratégias de negociação de preços quanto para abordagens regulatórias no mercado farmacêutico 43 .…”

Emerging themes and factors influencing the prices of biotherapeutics

“…To the best of our knowledge, no published research addresses this gap. The closest study (Borges Dos Santos et al, 2019) involves the categorization of the price factors into supply, demand, product, regulatory, and trading strategies. Yet another study in a similar domain describes the framework of four drivers of biotherapeutic prices; safety and efficacy, payment models, acceptability by physicians, and competition by biosimilars; which together establish the extent of cost savings (Mulcahy et al, 2014).…”

Determinants of drug prices: a systematic review of comparison studies

“…Various institutions, most prominently the WHO, are increasing their efforts in assessing pharmaceutical expenditure and its determinants as shown by a recent overview of grey literature. 49 Research institutes have set-up various inspiring collaborations with governmental and NGO using national databanks (such as Austria's Pharma Price Information, or PPI) or WHO data, which are rich and often available at request. 32 50 51 In addition, WHO now promotes and collects various drug price databases and occasionally publishes in peerreviewed journals.…”